Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology
Overview
Affiliations
Bronchopulmonary dysplasia (BPD) is the most common chronic complication of extreme preterm birth. The authors applied the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology to pharmacologic therapies found to prevent BPD. Caffeine and vitamin A are the only medications shown in high-quality studies to prevent BPD without the risk of clinically important adverse effects. Dexamethasone is effective for the prevention of BPD; but for many infants, the increased risks of hypertrophic cardiomyopathy, gastrointestinal perforation, and cerebral palsy outweigh this benefit. Several medications are currently under investigation for the prevention of BPD, but few are novel agents.
Beyond Bronchopulmonary Dysplasia: A Comprehensive Review of Chronic Lung Diseases in Neonates.
El-Atawi K, Abdul Wahab M, Alallah J, Osman M, Hassan M, Siwji Z Cureus. 2024; 16(7):e64804.
PMID: 39156276 PMC: 11329945. DOI: 10.7759/cureus.64804.
Strategies for the prevention of bronchopulmonary dysplasia.
Dini G, Ceccarelli S, Celi F Front Pediatr. 2024; 12:1439265.
PMID: 39114855 PMC: 11303306. DOI: 10.3389/fped.2024.1439265.
Strategies for cessation of caffeine administration in preterm infants.
Urru S, Geist M, Carlinger R, Bodrero E, Bruschettini M Cochrane Database Syst Rev. 2024; 7:CD015802.
PMID: 39045901 PMC: 11267609. DOI: 10.1002/14651858.CD015802.pub2.
Shah S, Shukla S, Nandula P, Vice S, Elgendy M, Gautam S J Perinatol. 2024; 44(7):947-952.
PMID: 38459373 DOI: 10.1038/s41372-024-01923-5.
Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants.
Tian C, Li D, Fu J Front Pediatr. 2022; 10:902437.
PMID: 35795332 PMC: 9251307. DOI: 10.3389/fped.2022.902437.